LIFEMINE THERAPEUTICS

Through our approach, we aim to bring unparalleled speed, predictability and scalability to small molecule drug discovery, offering the potential to rapidly advance multiple high-impact precision medicines to solve intractable disease challenges, irrespective of therapeutic area... LifeMine Therapeutics Expands Management Team with Appointments of Martin Stahl, Ph.D., as Chief Scientific Officer and Louis Plamondon, Ph.D., as Executive Vice President and Head of CMC... LifeMine is reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere. Our integrated, evolution-derived, AI- and genomically-enabled drug discovery engine is poised to deliver a pipeline of novel medicines that will conquer previously unconquerable human diseases.

Also known as: LifeMine Therapeutics Switzerland GmBH, LifeMine Therapeutics, Inc.

Primary location: Cambridge United States